3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Uveal Melanoma
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Lung Neoplasms
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Adenoma, Islet Cell
1
Interventions
pembrolizumab
6
Cetuximab
5
olaparib
3
atezolizumab
3
Injections
3
fludarabine
2
Trastuzumab
2
Docetaxel
2
Cyclophosphamide
2
Bevacizumab
2
zimberelimab
1
zansecimab
1
tocilizumab
1
taxane
1
spartalizumab
1
somatostatin receptor 2
1
ribociclib
1
pralsetinib
1
pertuzumab
1
pegylated granulocyte colony-stimulating factor
1
lenvatinib
1
ipatasertib
1
inavolisib
1
fludarabine phosphate
1
entrectinib
1
encorafenib
1
durvalumab
1
dapagliflozin
1
cemiplimab
1
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumors
×
aflibercept
×
1 year
×
Clear all
No trials found.